ID   ODO12_CORGL             Reviewed;        1221 AA.
AC   Q8NRC3; P96746; Q6M641;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2012, sequence version 2.
DT   07-APR-2021, entry version 123.
DE   RecName: Full=2-oxoglutarate dehydrogenase E1/E2 component;
DE            Short=ODH E1/E2 component;
DE   Includes:
DE     RecName: Full=2-oxoglutarate dehydrogenase E1 component;
DE              Short=ODH E1 component;
DE              EC=1.2.4.2 {ECO:0000269|PubMed:20675489, ECO:0000269|PubMed:9004499};
DE     AltName: Full=Alpha-ketoglutarate dehydrogenase E1 component;
DE              Short=KDH E1 component;
DE   Includes:
DE     RecName: Full=Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex;
DE              EC=2.3.1.61 {ECO:0000269|PubMed:20675489};
DE     AltName: Full=2-oxoglutarate dehydrogenase complex E2 component;
DE              Short=ODH E2 component;
DE              Short=OGDC-E2;
DE     AltName: Full=Dihydrolipoamide succinyltransferase;
GN   Name=odhA {ECO:0000312|EMBL:CAF19835.1}; OrderedLocusNames=Cgl1129, cg1280;
OS   Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 /
OS   JCM 1318 / LMG 3730 / NCIMB 10025).
OC   Bacteria; Actinobacteria; Corynebacteriales; Corynebacteriaceae;
OC   Corynebacterium.
OX   NCBI_TaxID=196627;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CATALYTIC ACTIVITY.
RC   STRAIN=AJ12036;
RX   PubMed=9004499; DOI=10.1099/13500872-142-12-3347;
RA   Usuda Y., Tujimoto N., Abe C., Asakura Y., Kimura E., Kawahara Y.,
RA   Kurahashi O., Matsui H.;
RT   "Molecular cloning of the Corynebacterium glutamicum ('Brevibacterium
RT   lactofermentum' AJ12036) odhA gene encoding a novel type of 2-oxoglutarate
RT   dehydrogenase.";
RL   Microbiology 142:3347-3354(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB
RC   10025;
RX   PubMed=12743753; DOI=10.1007/s00253-003-1328-1;
RA   Ikeda M., Nakagawa S.;
RT   "The Corynebacterium glutamicum genome: features and impacts on
RT   biotechnological processes.";
RL   Appl. Microbiol. Biotechnol. 62:99-109(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB
RC   10025 {ECO:0000312|EMBL:CAF19835.1};
RX   PubMed=12948626; DOI=10.1016/s0168-1656(03)00154-8;
RA   Kalinowski J., Bathe B., Bartels D., Bischoff N., Bott M., Burkovski A.,
RA   Dusch N., Eggeling L., Eikmanns B.J., Gaigalat L., Goesmann A.,
RA   Hartmann M., Huthmacher K., Kraemer R., Linke B., McHardy A.C., Meyer F.,
RA   Moeckel B., Pfefferle W., Puehler A., Rey D.A., Rueckert C., Rupp O.,
RA   Sahm H., Wendisch V.F., Wiegraebe I., Tauch A.;
RT   "The complete Corynebacterium glutamicum ATCC 13032 genome sequence and its
RT   impact on the production of L-aspartate-derived amino acids and vitamins.";
RL   J. Biotechnol. 104:5-25(2003).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-8, FUNCTION AS E1 AND E2 COMPONENT OF ODH, CATALYTIC
RP   ACTIVITY, KINETIC PARAMETERS, DOMAIN, LACK OF LIPOYLATION, ACTIVE SITE, AND
RP   MUTAGENESIS OF THR-258; HIS-316 AND GLN-320.
RC   STRAIN=ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB
RC   10025;
RX   PubMed=20675489; DOI=10.1128/jb.00597-10;
RA   Hoffelder M., Raasch K., van Ooyen J., Eggeling L.;
RT   "The E2 domain of OdhA of Corynebacterium glutamicum has
RT   succinyltransferase activity dependent on lipoyl residues of the
RT   acetyltransferase AceF.";
RL   J. Bacteriol. 192:5203-5211(2010).
RN   [5]
RP   INHIBITION BY ODHI, AND IDENTIFICATION IN THE ODH/PDH COMPLEX.
RC   STRAIN=ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB
RC   10025;
RX   PubMed=16522631; DOI=10.1074/jbc.m512515200;
RA   Niebisch A., Kabus A., Schultz C., Weil B., Bott M.;
RT   "Corynebacterial protein kinase G controls 2-oxoglutarate dehydrogenase
RT   activity via the phosphorylation status of the OdhI protein.";
RL   J. Biol. Chem. 281:12300-12307(2006).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 13869 / DSMZ 1412 / NCIMB 9567;
RX   PubMed=17158630; DOI=10.1128/aem.01867-06;
RA   Asakura Y., Kimura E., Usuda Y., Kawahara Y., Matsui K., Osumi T.,
RA   Nakamatsu T.;
RT   "Altered metabolic flux due to deletion of odhA causes L-glutamate
RT   overproduction in Corynebacterium glutamicum.";
RL   Appl. Environ. Microbiol. 73:1308-1319(2007).
RN   [7]
RP   DOMAIN, ACTIVITY REGULATION, AND INTERACTION WITH ODHI.
RC   STRAIN=ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB
RC   10025;
RX   PubMed=20303957; DOI=10.1016/j.febslet.2010.03.028;
RA   Krawczyk S., Raasch K., Schultz C., Hoffelder M., Eggeling L., Bott M.;
RT   "The FHA domain of OdhI interacts with the carboxyterminal 2-oxoglutarate
RT   dehydrogenase domain of OdhA in Corynebacterium glutamicum.";
RL   FEBS Lett. 584:1463-1468(2010).
CC   -!- FUNCTION: Catalyzes the E1 and E2 reactions as part of 2-oxoglutarate
CC       dehydrogenase (ODH) activity, to convert 2-oxoglutarate to succinyl-CoA
CC       and CO(2). OdhA has reductase activity with 2-oxoglutarate but does not
CC       react with pyruvate, and also displays transsuccinylase but no
CC       transacetylase activity. Since OdhA is not lipoylated, the
CC       succinyltransferase activity of its E2 domain is dependent on lipoyl
CC       residues of the acetyltransferase AceF. {ECO:0000269|PubMed:20675489}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + [dihydrolipoyllysine-residue
CC         succinyltransferase]-(R)-N(6)-lipoyl-L-lysine + H(+) =
CC         [dihydrolipoyllysine-residue succinyltransferase]-(R)-N(6)-(S(8)-
CC         succinyldihydrolipoyl)-L-lysine + CO2; Xref=Rhea:RHEA:12188,
CC         Rhea:RHEA-COMP:10483, Rhea:RHEA-COMP:10484, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:16810, ChEBI:CHEBI:83099,
CC         ChEBI:CHEBI:83120; EC=1.2.4.2; Evidence={ECO:0000269|PubMed:20675489,
CC         ECO:0000269|PubMed:9004499};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-N(6)-dihydrolipoyl-L-lysyl-[2-oxoglutarate dehydrogenase
CC         complex component E2] + succinyl-CoA = (R)-N(6)-(S(8)-
CC         succinyldihydrolipoyl)-L-lysyl-[2-oxoglutarate dehydrogenase complex
CC         component E2] + CoA; Xref=Rhea:RHEA:15213, Rhea:RHEA-COMP:10581,
CC         Rhea:RHEA-COMP:10582, ChEBI:CHEBI:57287, ChEBI:CHEBI:57292,
CC         ChEBI:CHEBI:83100, ChEBI:CHEBI:83120; EC=2.3.1.61;
CC         Evidence={ECO:0000269|PubMed:20675489};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- COFACTOR:
CC       Name=thiamine diphosphate; Xref=ChEBI:CHEBI:58937;
CC         Evidence={ECO:0000250|UniProtKB:P0AFG3};
CC   -!- ACTIVITY REGULATION: Inhibited by unphosphorylated OdhI, but not by
CC       phosphorylated OdhI. {ECO:0000269|PubMed:20303957}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.014 mM for 2-oxoglutarate {ECO:0000269|PubMed:20675489};
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; succinyl-
CC       CoA from 2-oxoglutarate (dehydrogenase route): step 1/1.
CC   -!- SUBUNIT: Homodimer (By similarity). Part of an unusual ODH/PDH
CC       supercomplex, consisting of AceE (E1), AceF (E2), and Lpd (E3) together
CC       with OdhA (E1+E2). Interacts with the FHA domain of unphosphorylated
CC       OdhI via its C-terminal dehydrogenase domain. {ECO:0000250,
CC       ECO:0000269|PubMed:16522631, ECO:0000269|PubMed:20303957}.
CC   -!- INTERACTION:
CC       Q8NRC3; Q8NQJ3: odhI; NbExp=2; IntAct=EBI-7868591, EBI-7868645;
CC   -!- DOMAIN: OdhA is a fusion protein with two major domains exhibiting
CC       structural features of an E1 and E2 protein, and a short sequence
CC       stretch of E1 localized at the N-terminus, which is connected by a
CC       linker region to the rest of the protein. Deletion of individual parts
CC       of odhA show that all parts of odhA are required for a functional
CC       tricarboxylic acid cycle in C.glutamicum; the ODH activity is in fact
CC       completely abolished in each of these mutants, and the PDH activity is
CC       significantly reduced, which could indicate that the overall structure
CC       of the supercomplex is disturbed. {ECO:0000269|PubMed:20303957,
CC       ECO:0000269|PubMed:20675489}.
CC   -!- DISRUPTION PHENOTYPE: Strains lacking this gene completely lack 2-
CC       oxoglutarate dehydrogenase activity. Deletion of odhA also causes L-
CC       glutamate overproduction and accumulation during growth.
CC       {ECO:0000269|PubMed:17158630}.
CC   -!- MISCELLANEOUS: Is non-lipoylated. In contrast, the E2 component AceF is
CC       the prominent lipoylated protein in C.glutamicum.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the alpha-
CC       ketoglutarate dehydrogenase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the 2-oxoacid
CC       dehydrogenase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB98522.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAF19835.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D84102; BAA12222.2; -; Genomic_DNA.
DR   EMBL; BA000036; BAB98522.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BX927151; CAF19835.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; NP_600357.3; NC_003450.3.
DR   RefSeq; WP_011014138.1; NC_006958.1.
DR   SMR; Q8NRC3; -.
DR   IntAct; Q8NRC3; 1.
DR   MINT; Q8NRC3; -.
DR   STRING; 196627.cg1280; -.
DR   PRIDE; Q8NRC3; -.
DR   EnsemblBacteria; BAB98522; BAB98522; BAB98522.
DR   KEGG; cgb:cg1280; -.
DR   KEGG; cgl:NCgl1084; -.
DR   PATRIC; fig|196627.13.peg.1108; -.
DR   eggNOG; COG0508; Bacteria.
DR   eggNOG; COG0567; Bacteria.
DR   HOGENOM; CLU_004709_1_0_11; -.
DR   BioCyc; CORYNE:G18NG-10701-MONOMER; -.
DR   SABIO-RK; Q8NRC3; -.
DR   UniPathway; UPA00223; UER00997.
DR   Proteomes; UP000000582; Chromosome.
DR   GO; GO:0004149; F:dihydrolipoyllysine-residue succinyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004591; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; IEA:UniProtKB-EC.
DR   GO; GO:0030976; F:thiamine pyrophosphate binding; IEA:InterPro.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.30.559.10; -; 1.
DR   Gene3D; 3.40.50.11610; -; 1.
DR   InterPro; IPR001078; 2-oxoacid_DH_actylTfrase.
DR   InterPro; IPR032106; 2-oxogl_dehyd_N.
DR   InterPro; IPR011603; 2oxoglutarate_DH_E1.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001017; DH_E1.
DR   InterPro; IPR031717; KGD_C.
DR   InterPro; IPR042179; KGD_C_sf.
DR   InterPro; IPR029061; THDP-binding.
DR   InterPro; IPR005475; Transketolase-like_Pyr-bd.
DR   PANTHER; PTHR23152; PTHR23152; 1.
DR   Pfam; PF00198; 2-oxoacid_dh; 1.
DR   Pfam; PF16078; 2-oxogl_dehyd_N; 1.
DR   Pfam; PF00676; E1_dh; 1.
DR   Pfam; PF16870; OxoGdeHyase_C; 1.
DR   Pfam; PF02779; Transket_pyr; 1.
DR   PIRSF; PIRSF000157; Oxoglu_dh_E1; 1.
DR   SMART; SM00861; Transket_pyr; 1.
DR   SUPFAM; SSF52518; SSF52518; 2.
DR   TIGRFAMs; TIGR00239; 2oxo_dh_E1; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Direct protein sequencing; Magnesium; Metal-binding;
KW   Multifunctional enzyme; Oxidoreductase; Reference proteome;
KW   Thiamine pyrophosphate; Transferase; Tricarboxylic acid cycle.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:20675489"
FT   CHAIN           2..1221
FT                   /note="2-oxoglutarate dehydrogenase E1/E2 component"
FT                   /id="PRO_0000273521"
FT   REGION          2..40
FT                   /note="2-oxoglutarate dehydrogenase E1, N-terminal part"
FT   REGION          41..89
FT                   /note="Linker"
FT   REGION          90..337
FT                   /note="Succinyltransferase E2"
FT   REGION          338..1221
FT                   /note="2-oxoglutarate dehydrogenase E1, C-terminal part"
FT   REGION          543..544
FT                   /note="Thiamine pyrophosphate binding"
FT                   /evidence="ECO:0000250"
FT   REGION          608..610
FT                   /note="Thiamine pyrophosphate binding"
FT                   /evidence="ECO:0000250"
FT   REGION          645..647
FT                   /note="Thiamine pyrophosphate binding"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        316
FT                   /note="Proton acceptor; for succinyltransferase activity"
FT                   /evidence="ECO:0000269|PubMed:20675489"
FT   METAL           645
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250"
FT   METAL           678
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250"
FT   METAL           680
FT                   /note="Magnesium; via carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         583
FT                   /note="2-oxoglutarate"
FT                   /evidence="ECO:0000250"
FT   BINDING         608
FT                   /note="2-oxoglutarate"
FT                   /evidence="ECO:0000250"
FT   BINDING         949
FT                   /note="Thiamine pyrophosphate"
FT                   /evidence="ECO:0000250"
FT   BINDING         1017
FT                   /note="2-oxoglutarate"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         258
FT                   /note="T->A: Loss of E2 succinyltransferase activity, but
FT                   nearly no effect on E1 dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:20675489"
FT   MUTAGEN         316
FT                   /note="H->C: Loss of E2 succinyltransferase activity, and
FT                   2-fold reduction in E1 dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:20675489"
FT   MUTAGEN         320
FT                   /note="Q->D: Slight reduction in E2 succinyltransferase
FT                   activity and in E1 dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:20675489"
FT   CONFLICT        44
FT                   /note="T -> A (in Ref. 1; BAA12222)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        82
FT                   /note="D -> A (in Ref. 1; BAA12222)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        238
FT                   /note="A -> T (in Ref. 1; BAA12222)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        413
FT                   /note="N -> S (in Ref. 1; BAA12222)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        424
FT                   /note="N -> S (in Ref. 1; BAA12222)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        967
FT                   /note="I -> V (in Ref. 1; BAA12222)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1093
FT                   /note="N -> D (in Ref. 1; BAA12222)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1221 AA;  134664 MW;  BF0A1827EA1B0080 CRC64;
     MSSASTFGQN AWLVDEMFQQ FQKDPKSVDK EWRELFEAQG GPNTTPATTE AQPSAPKESA
     KPAPKAAPAA KAAPRVETKP ADKTAPKAKE SSVPQQPKLP EPGQTPIRGI FKSIAKNMDI
     SLEIPTATSV RDMPARLMFE NRAMVNDQLK RTRGGKISFT HIIGYAMVKA VMAHPDMNNS
     YDVIDGKPTL IVPEHINLGL AIDLPQKDGS RALVVAAIKE TEKMNFSEFL AAYEDIVARS
     RKGKLTMDDY QGVTVSLTNP GGIGTRHSVP RLTKGQGTII GVGSMDYPAE FQGASEDRLA
     ELGVGKLVTI TSTYDHRVIQ GAVSGEFLRT MSRLLTDDSF WDEIFDAMNV PYTPMRWAQD
     VPNTGVDKNT RVMQLIEAYR SRGHLIADTN PLSWVQPGMP VPDHRDLDIE THNLTIWDLD
     RTFNVGGFGG KETMTLREVL SRLRAAYTLK VGSEYTHILD RDERTWLQDR LEAGMPKPTQ
     AEQKYILQKL NAAEAFENFL QTKYVGQKRF SLEGAEALIP LMDSAIDTAA GQGLDEVVIG
     MPHRGRLNVL FNIVGKPLAS IFNEFEGQME QGQIGGSGDV KYHLGSEGQH LQMFGDGEIK
     VSLTANPSHL EAVNPVMEGI VRAKQDYLDK GVDGKTVVPL LLHGDAAFAG LGIVPETINL
     AKLRGYDVGG TIHIVVNNQI GFTTTPDSSR SMHYATDYAK AFGCPVFHVN GDDPEAVVWV
     GQLATEYRRR FGKDVFIDLV CYRLRGHNEA DDPSMTQPKM YELITGRETV RAQYTEDLLG
     RGDLSNEDAE AVVRDFHDQM ESVFNEVKEG GKKQAEAQTG ITGSQKLPHG LETNISREEL
     LELGQAFANT PEGFNYHPRV APVAKKRVSS VTEGGIDWAW GELLAFGSLA NSGRLVRLAG
     EDSRRGTFTQ RHAVAIDPAT AEEFNPLHEL AQSKGNNGKF LVYNSALTEY AGMGFEYGYS
     VGNEDSIVAW EAQFGDFANG AQTIIDEYVS SGEAKWGQTS KLILLLPHGY EGQGPDHSSA
     RIERFLQLCA EGSMTVAQPS TPANHFHLLR RHALSDLKRP LVIFTPKSML RNKAAASAPE
     DFTEVTKFQS VINDPNVADA AKVKKVMLVS GKLYYELAKR KEKDGRDDIA IVRIEMLHPI
     PFNRISEALA GYPNAEEVLF VQDEPANQGP WPFYQEHLPE LIPNMPKMRR VSRRAQSSTA
     TGVAKVHQLE EKQLIDEAFE A
//
